The 21-Gene Recurrence Score in Clinically High-Risk Lobular and Ductal Breast Cancer: A National Cancer Database Study

OBJECTIVE: The aim of this study was to evaluate whether patients with invasive lobular carcinoma (ILC) are more likely to have discordant clinical and genomic risk than those with invasive ductal carcinoma (IDC) when using the 21-gene recurrence score (RS), and to assess overall survival outcomes o...

Descripción completa

Detalles Bibliográficos
Autores principales: Abel, Mary Kathryn, Shui, Amy M., Chien, A. Jo, Rugo, Hope S., Melisko, Michelle, Baehner, Frederick, Mukhtar, Rita A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Breast Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550696/
https://www.ncbi.nlm.nih.gov/pubmed/35810223
http://dx.doi.org/10.1245/s10434-022-12065-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550696/
https://www.ncbi.nlm.nih.gov/pubmed/35810223
http://dx.doi.org/10.1245/s10434-022-12065-3

Ejemplares similares